IL6 and colorectal carcinoma: Besides TGF-β, other factors such as IL-6, IL-33, IL-8, IL-23, PGE2 and IDO-1 have shown similar immunomodulatory properties and impact in metastasis development and patient prognosis in CRC (63–74).